Welcome to our dedicated page for Corteva SEC filings (Ticker: CTVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Corteva, Inc. (NYSE: CTVA), a global pure-play agriculture company focused on seed, crop protection, and digital products and services. Corteva’s filings include current reports on Form 8-K, annual and quarterly reports, and other disclosures that outline its financial condition, segment performance and significant corporate events.
Recent Form 8-K filings show how Corteva reports results of operations and financial condition, furnishing earnings press releases and financial statement schedules for specific quarters. These filings describe performance in the Seed and Crop Protection segments, regional trends, and management’s guidance ranges. Other 8-Ks address material corporate developments, such as the announced plan to separate the company into two independent, publicly traded entities through a tax-free spin-off, and executive leadership changes in the legal function.
Through this filings feed, users can review Corteva’s official disclosures about its planned separation into a crop protection-focused business (referred to as New Corteva) and a seed-focused business (referred to as SpinCo), as well as details on dividends, capital allocation, and research and development investment discussed in furnished materials. The filings also confirm that Corteva’s common stock is registered on the New York Stock Exchange under the symbol CTVA.
Stock Titan enhances these documents with AI-powered summaries that explain the key points of lengthy filings, helping readers quickly understand segment results, guidance updates and major strategic announcements. Real-time updates from EDGAR ensure that new 8-Ks, 10-Qs, 10-Ks and other forms appear promptly, while specialized views of insider-related forms such as Form 4 allow users to monitor reported transactions by directors and executive officers where available.
Corteva, Inc. filed a Rule 144 notice to sell 8,311 shares of its common stock.
The filing lists specific planned transfers tied to equity awards and an option exercise, including 619 shares from a restricted stock unit vesting on
Corteva, Inc. officer Brian Titus reported a small insider transaction involving company common stock. On February 18, 2026, 113 shares were disposed of under code F as a tax-withholding disposition, at a reported price of $76.59 per share. According to the footnote, these shares were withheld by Corteva to pay taxes due upon the vesting of previously granted restricted stock units, rather than sold in an open-market trade. After this transaction, Titus directly held about 12,222 shares of Corteva common stock.
Corteva, Inc. senior vice president and chief people officer Audrey Grimm reported a Form 4 transaction involving a tax-related share disposition. On the vesting of previously granted restricted stock units, 399 shares of common stock were withheld by Corteva to cover taxes at $76.59 per share, rather than being sold on the open market. After this withholding, Grimm directly held 24,058.0748 Corteva common shares.
Corteva, Inc. officer Samuel R. Eathington reported an administrative share disposition related to equity compensation. On February 18, 2026, 524 shares of common stock at
After this tax-withholding transaction, Eathington directly owned 71,917.8725 shares of Corteva common stock. The filing also notes an additional 4,384 shares held indirectly in a family trust, reflecting separate indirect ownership.
Corteva, Inc. executive vice president and chief financial officer David Paul Johnson reported a tax-withholding disposition of common stock related to equity compensation. On February 18, 2026, 704 shares of Corteva common stock were withheld at
Corteva, Inc. executive vice president of the Seed Business Unit Judd M. O'Connor reported a tax-related share withholding tied to vested restricted stock units. On the transaction date, 352.0000 shares of common stock were withheld by the issuer at $76.5900 per share to cover tax obligations, classified as a tax-withholding disposition rather than an open-market sale. After this transaction, O'Connor directly owned 38,468.6073 shares of Corteva common stock and indirectly held 258.7422 shares in a 401(k) plan.
Corteva, Inc. executive Robert D. King, EVP of the Crop Protection Business, reported a tax-related share disposition. On the transaction date, 526 shares of common stock at
Corteva, Inc. Chief Executive Officer Charles V. Magro reported a tax-related share withholding transaction. On February 18, 2026, 5,319 shares of common stock were withheld at $76.59 per share to cover taxes due upon vesting of previously granted restricted stock units. This was a tax-withholding disposition, not an open-market sale. After this transaction, Magro directly owned 251,822.1357 shares of Corteva common stock.
Corteva, Inc. (CTVA)
The Seed segment develops germplasm and trait technologies, including Enlist E3 soybeans, and markets through a multi-channel system led by its Pioneer agency model. Crop Protection offers herbicides, insecticides, fungicides, nitrogen stabilizers and biologicals under brands such as ZORVEC, ENLIST and ARYLEX.
On October 1, 2025, Corteva announced its intent to separate its Seed and Crop Protection businesses into two standalone, publicly traded companies in a transaction intended to be tax-free for U.S. federal income tax purposes. The filing also discusses extensive regulatory, environmental, competitive and geopolitical risks that could affect future results.
Corteva, Inc. director Janet Plaut Giesselman reported acquiring additional stock-based compensation units. On January 30, 2026, she acquired 106.456 common stock units at $72.8 per share under Corteva’s Stock Accumulation and Deferred Compensation Plan for Directors, which allows non-employee directors to defer cash fees into stock units.
After this transaction, she beneficially owned 17,617.8236 Corteva common shares, which includes 46.4678 shares obtained through dividend reinvestment. All shares are reported as held directly.